![Day One Biopharmaceuticals Inc](/common/images/company/N_DAWN.png)
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 0.342172797263 | 11.69 | 12.54 | 11.69 | 662045 | 12.11828737 | CS |
4 | -0.5 | -4.08830744072 | 12.23 | 13.53 | 11.52 | 820097 | 12.38319098 | CS |
12 | -1.87 | -13.75 | 13.6 | 14.46 | 11.13 | 985177 | 12.5785501 | CS |
26 | -2.26 | -16.1543959971 | 13.99 | 16.76 | 11.13 | 1013889 | 13.60059161 | CS |
52 | -3.46 | -22.7781435155 | 15.19 | 18.0699 | 11.13 | 1022269 | 14.23580607 | CS |
156 | -1.92 | -14.0659340659 | 13.65 | 28.3499 | 5.44 | 883479 | 14.88316464 | CS |
260 | -13.27 | -53.08 | 25 | 28.699 | 5.44 | 741605 | 15.0868625 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관